Flavonoid Market Expected to Reach $2.9 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Flavonoid Market," The flavonoid market was valued at $1.7 billion in 2022, and is estimated to reach $2.9 billion by 2032, growing at a CAGR of 5.8% from 2023 to 2032.

Flavonoids are a class of naturally occurring plant compounds known for their antioxidant properties and potential health benefits. They are found in various fruits, vegetables, teas, and other plant-based foods. These naturally occurring plant compounds are in demand for their antioxidant properties and potential health advantages. The market includes growers, processors, manufacturers, and distributors of flavonoid-rich foods, supplements, and ingredients, serving consumers looking for wellness-oriented choices, which resutls in flavonoid market trends.

The rising consumer awareness regarding health benefits offered by flavonoid as a supplement is anticipated to remain a major driving factor for the growth of the flavonoid market over the forecast period. Inherent benefits of the flavonoid in pharmaceutical applications to treat cancer, heart health and other chronic and cardiovascular diseases have also contributed toward flavonoid market growth.

The aging population is expected to provide lucrative opportunities for the expansion of cosmetic industry in countries such as Japan, Latin America, and others. According to WHO, the population in Latin America is aging at a rapid pace. Thus, this in turn is expected to offer huge opportunities for the growth of flavonoid market from the cosmetics industry during the flavonoid forecast period in terms of value sales. In addition to this, consumption of flavonoids as a dietary supplement has resulted in positive outcomes, particularly in patients on statin medications. Thereby, the aforementioned factors are expected to drive the growth of the flavonoid market during the forecast period in terms of value sales.

Flavonoid in the pharmaceutical industry is used for it has polyphenolic structure, used for different pharmacological activities. The flavonoid acts as an antioxidant due to the presence of Hydroxyl groups. The flavonoid helps in preventing radicals that lead to oxidative stress and it also helps in treating various diseases including cardiovascular disease, cancer, arthritis, respiratory disorders, and early ageing. Thus, this in turn has propelled the demand for flavonoids such as flavones, isoflavones, anthocyanidins and others from the pharmaceuticals industry. This, in turn, has bolstered the growth of the overall flavonoid market size in terms of value sales.

Pharmaceutical applications are boosting flavonoid market demand by driving research into their therapeutic potential for various health conditions. As studies explore flavonoids' efficacy in areas such as cardiovascular health and cancer prevention, pharmaceutical companies are increasingly interested in developing flavonoid-based drugs, expanding the market by leveraging their medicinal properties. Moreover, clean-label product trends, emphasizing natural ingredients and transparency, boost flavonoid market demand. Consumers prefer flavonoids over synthetic additives, seeking healthier choices. Manufacturers respond by incorporating flavonoid-rich, natural ingredients, aligning with clean label preferences, and fostering greater consumer trust in product quality, ultimately propelling flavonoid market growth.

The COVID-19 pandemic has underscored the significance of health and immune system support, resulting in a heightened consumer interest in products offering potential health benefits, including those containing flavonoids. This renewed focus on wellness has driven demand for flavonoid-rich foods and supplements. Consumers seek functional foods and beverages offering health benefits beyond basic nutrition. Manufacturers have responded by incorporating flavonoid-rich ingredients into products, such as antioxidant-infused beverages and fortified snacks, thus driving the market growth.

The flavonoid market forecast into product type, form, application, and region. By product type, it is classified into isoflavones, anthocyanin and others. By form, the market is bifurcated into powder and liquid. By application, it is divided into pharmaceuticals, nutraceuticals, food & beverages and cosmetics. Region-wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (France, Germany, Italy, Spain, the UK., the Netherlands, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Argentina and Rest of LAMEA).

By product type, the isoflavones segment accounted for the highest flavonoid market share in 2022. Isoflavones are a type of organic compound and are one of the types of flavonoids. They are used in the production of cosmetics and various skin care products such as moisturizers and face creams. Moreover, isoflavones are also widely used in the pharmaceutical industry to treat a variety of diseases. This in turn has driven the growth of the overall flavonoid market. However, the anthocyanin segment in the flavonoid market is expected to be the fastest-growing segment during the forecast period in terms of value sales.

By form, the powder segment accounted for the highest market share in the global flavonoid market in 2022 and is also expected to retain its dominance during the forecast period. The flavonoids available in powdered formats are majorly used in the pharmaceuticals industry, are also used in functional food and are available as phytoestrogen supplements, which are contributing to driving the growth of the market. However, a liquid segment in the flavonoid market is expected to be the fastest-growing segment during the forecast period in terms of value sales.

By application, the pharmaceuticals segment accounted for the highest market share in the global flavonoid market in 2022 and is also expected to retain its dominance during the forecast period and creates flavonoid market opportunities. This is mainly because flavonoid is an immunity-boosting enzyme that reduces the possibility of cancer, cardiovascular disease, and others.  Thus, this has driven the demand for flavonoids used in the pharmaceuticals industry. However, the food & beverages segment in the flavonoid industry is expected to be the fastest-growing segment during the forecast period in terms of value sales.

North America accounted for the highest market share in 2022, owing to the consumption of flavonoid as a supplement increasing among the consumers in this region. This is mainly due to high incidences of diseases, such as high cholesterol, high blood pressure, coronary heart diseases, atherosclerosis, and congestive heart failure. Flavonoid helps protect the heart and blood vessels from getting damaged. Therefore, North America has created a prolific flavonoid market demand over a period. However, Asia-Pacific is expected to be the fastest-growing market during the market forecast period.

Some of the key players in the flavonoid market analysis include BASF SE, Ingredients By Nature, Foodchem International Corporation, Conagen, Inc., Bordas S.A., Cayman Chemical Company, Biosynth AG, Santa Cruz Biotechnology, Inc., Archer-Daniels-Midland Company, and Givaudan SA.

Key Findings of the Study

• Based on product type, the Isoflavones segment is expected to dominate the market during the forecast period.
• Based on Form, the Liquid segment is expected to grow with the highest CAGR during the forecast period.
• Based on Application, the Pharmaceutical segment is expected to dominate the market during the forecast period. 
• Asia-Pacific is expected to grow with the highest CAGR of 6.7% during the forecast period.